1. Home
  2. OCUL vs KSS Comparison

OCUL vs KSS Comparison

Compare OCUL & KSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • KSS
  • Stock Information
  • Founded
  • OCUL 2006
  • KSS 1962
  • Country
  • OCUL United States
  • KSS United States
  • Employees
  • OCUL N/A
  • KSS N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • KSS Department/Specialty Retail Stores
  • Sector
  • OCUL Health Care
  • KSS Consumer Discretionary
  • Exchange
  • OCUL Nasdaq
  • KSS Nasdaq
  • Market Cap
  • OCUL 2.3B
  • KSS 1.9B
  • IPO Year
  • OCUL 2014
  • KSS 1992
  • Fundamental
  • Price
  • OCUL $11.77
  • KSS $15.70
  • Analyst Decision
  • OCUL Strong Buy
  • KSS Sell
  • Analyst Count
  • OCUL 9
  • KSS 14
  • Target Price
  • OCUL $22.63
  • KSS $11.88
  • AVG Volume (30 Days)
  • OCUL 3.1M
  • KSS 4.3M
  • Earning Date
  • OCUL 11-04-2025
  • KSS 11-25-2025
  • Dividend Yield
  • OCUL N/A
  • KSS 3.14%
  • EPS Growth
  • OCUL N/A
  • KSS N/A
  • EPS
  • OCUL N/A
  • KSS 1.86
  • Revenue
  • OCUL $56,664,000.00
  • KSS $15,886,000,000.00
  • Revenue This Year
  • OCUL N/A
  • KSS N/A
  • Revenue Next Year
  • OCUL $17.75
  • KSS N/A
  • P/E Ratio
  • OCUL N/A
  • KSS $8.55
  • Revenue Growth
  • OCUL N/A
  • KSS N/A
  • 52 Week Low
  • OCUL $5.79
  • KSS $6.04
  • 52 Week High
  • OCUL $13.85
  • KSS $21.39
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 50.07
  • KSS 47.88
  • Support Level
  • OCUL $11.31
  • KSS $16.14
  • Resistance Level
  • OCUL $11.78
  • KSS $17.15
  • Average True Range (ATR)
  • OCUL 0.47
  • KSS 0.73
  • MACD
  • OCUL 0.01
  • KSS -0.02
  • Stochastic Oscillator
  • OCUL 54.47
  • KSS 48.67

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About KSS Kohl's Corporation

Kohl's operates about 1,150 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also has a large digital sales operation. Women's apparel is Kohl's largest category, having generated 25% of its 2024 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.

Share on Social Networks: